Early Access — free while we kick the tires
EdgarHawk

Healy Susan L.

EVP, Chief Financial Officer

Officer
2 filings analyzed · 1 company · Latest 2025-08-14

Companies

Company Buys Sells Direction
Crocs, Inc. CROX 2 0 Net buying

Activity

August 2025
2025-08-14 Crocs, Inc. CROX
medium
Buy
2,000 shares
$153,120
Significance 4/10

CFO Susan L. Healy bought 2,000 CROX shares at $76.56 on 2025-08-12; stock now -43.0% from 52-week high, down -15.7% in 30 days.

Susan L. Healy, EVP and Chief Financial Officer, purchased 2,000 shares worth $153,120.00 at $76.56, expanding her CROX holdings to 50,078 shares. The timing context is notably unfavorable: CROX has declined -43.0% from its 52-week high and -15.7% in the past 30 days, placing the transaction near a depressed price point. However, Healy's trading history at this ticker shows limited predictive power—her one prior CROX purchase in November 2024 yielded -10.8% over 90 days, and across all her open-market transactions, she has achieved a 0% win rate at the 90-day horizon. The company faces structural headwinds: net income stands at $-492.3M against revenue of $1.1B, despite annual revenue growth of +3.5%. This buy occurs in a company under financial stress with an insider whose timing pattern has not demonstrated accuracy in either direction.

November 2024
2024-11-14 Crocs, Inc. CROX
medium
Buy
1,000 shares
$99,702
Significance 4/10

CFO Healy buys 1,000 shares of CROX at $99.70; stock down 28.9% in 30 days, near 52-week low

CFO Susan L. Healy purchased 1,000 shares at $99.70 while Crocs stock has declined 28.9% over the prior 30 days and trades $99.86 versus a 52-week high of $159.68. Her post-transaction holdings total 22,652 shares, representing a 4.6% increase from prior holdings. Despite this acquisition, the stock's recent steep drawdown and current valuation position at 37.5% below its annual peak present a mixed signal: the buy occurs amid significant recent weakness rather than at elevated prices. The company's fundamentals remain solid with annual revenue growth of 11.5% and a P/E of 6.97, but near-term price momentum is notably negative.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access